• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

内脏脂肪蓄积作为代谢综合征治疗靶点的研究进展。

Visceral adiposity as a target for the management of the metabolic syndrome.

机构信息

Department of Metabolic Medicine, Graduate School of Medicine, Osaka University, Japan.

出版信息

Ann Med. 2012 May;44(3):233-41. doi: 10.3109/07853890.2011.564202. Epub 2011 May 25.

DOI:10.3109/07853890.2011.564202
PMID:21612331
Abstract

Atherosclerosis, the underlying cause of atherosclerotic cardiovascular disease (ACVD), develops due not only to a single cardiovascular risk factor but to a variety of complex factors. The concept of the multiple cardiometabolic risk factor clustering syndrome has been proposed as a highly atherogenic state, independent of hypercholesterolemia and smoking. Body fat distribution, especially visceral fat accumulation, is a major correlate of a cluster of diabetogenic, atherogenic, prothrombotic, and proinflammatory metabolic abnormalities referred to as the metabolic syndrome, with dysfunctional adipocytes and dysregulated production of adipocytokines (hypoadiponectinemia). Medical research has focused on visceral adiposity as an important component of the syndrome in Japanese subjects with a mild degree of adiposity compared with Western subjects. For the prevention of ACVD at least in Japan, it might be practical to stratify subjects with multiple risk factors for atherosclerotic cardiovascular disease based on visceral fat accumulation. Visceral fat reduction through health promotion programs using risk factor-oriented approaches may be effective in reducing ACVD events, as well as producing improvement in risks and hypoadiponectinemia. This review article discusses visceral adiposity as a key player in the syndrome. Visceral fat reduction with life-style modification is a potentially useful strategy in the prevention of ACVD in patients with the metabolic syndrome.

摘要

动脉粥样硬化是动脉粥样硬化性心血管疾病(ACVD)的根本原因,其发生不仅与单一心血管危险因素有关,还与多种复杂因素有关。多种心血管代谢危险因素聚集综合征的概念被提出,作为一种高度致动脉粥样硬化的状态,独立于高胆固醇血症和吸烟。体脂分布,尤其是内脏脂肪堆积,是与糖尿病、动脉粥样硬化、血栓形成和炎症代谢异常等多种代谢异常相关的一个重要指标,这些异常被称为代谢综合征,伴有功能失调的脂肪细胞和失调的脂肪细胞因子(低 adiponectinemia)产生。医学研究集中在内脏肥胖作为与西方人群相比,日本人群中肥胖程度较轻的综合征的一个重要组成部分。为了预防 ACVD,至少在日本,根据内脏脂肪堆积情况,对具有动脉粥样硬化性心血管疾病多种危险因素的患者进行分层可能是实用的。通过使用以危险因素为导向的方法进行健康促进计划来减少内脏脂肪,可能会有效降低 ACVD 事件的发生,同时改善风险和低 adiponectinemia。本文讨论了内脏脂肪作为该综合征的关键因素。通过生活方式改变来减少内脏脂肪是预防代谢综合征患者 ACVD 的一种潜在有用的策略。

相似文献

1
Visceral adiposity as a target for the management of the metabolic syndrome.内脏脂肪蓄积作为代谢综合征治疗靶点的研究进展。
Ann Med. 2012 May;44(3):233-41. doi: 10.3109/07853890.2011.564202. Epub 2011 May 25.
2
The role of fat topology in the risk of disease.脂肪拓扑结构在疾病风险中的作用。
Int J Obes (Lond). 2008 Dec;32 Suppl 7:S83-92. doi: 10.1038/ijo.2008.243.
3
Clinical importance of assessment of type 2 diabetes mellitus with visceral obesity. A Japanese perspective.2型糖尿病合并内脏肥胖评估的临床重要性:日本视角
Curr Diabetes Rev. 2012 Mar;8(2):84-91. doi: 10.2174/157339912799424546.
4
Population Approaches Targeting Metabolic Syndrome Focusing on Japanese Trials.以日本试验为重点的针对代谢综合征的人群方法。
Nutrients. 2019 Jun 25;11(6):1430. doi: 10.3390/nu11061430.
5
LIPID ACCUMULATION PRODUCT, VISCERAL ADIPOSITY INDEX, AND CHINESE VISCERAL ADIPOSITY INDEX AS MARKERS OF CARDIOMETABOLIC RISK IN ADULT GROWTH HORMONE DEFICIENCY PATIENTS: A CROSS-SECTIONAL STUDY.脂积累产物、内脏脂肪指数和中国内脏脂肪指数作为成年生长激素缺乏症患者心血管代谢风险的标志物:一项横断面研究。
Endocr Pract. 2018 Jan;24(1):33-39. doi: 10.4158/EP-2017-0007. Epub 2017 Nov 16.
6
The concept of metabolic syndrome: contribution of visceral fat accumulation and its molecular mechanism.代谢综合征概念:内脏脂肪堆积的贡献及其分子机制。
J Atheroscler Thromb. 2011;18(8):629-39. doi: 10.5551/jat.7922. Epub 2011 Jul 8.
7
Association of obesity, visceral adiposity, and sarcopenia with an increased risk of metabolic syndrome: A retrospective study.肥胖、内脏脂肪堆积和肌肉减少症与代谢综合征风险增加的关联:一项回顾性研究。
PLoS One. 2021 Aug 17;16(8):e0256083. doi: 10.1371/journal.pone.0256083. eCollection 2021.
8
Sensitivity of various body indices and visceral adiposity index in predicting metabolic syndrome among Chinese patients with adult growth hormone deficiency.中国成年生长激素缺乏患者中各种身体指标和内脏脂肪指数对代谢综合征的预测敏感性
J Endocrinol Invest. 2017 Jun;40(6):653-661. doi: 10.1007/s40618-017-0621-2. Epub 2017 Feb 23.
9
Absolute value of visceral fat area measured on computed tomography scans and obesity-related cardiovascular risk factors in large-scale Japanese general population (the VACATION-J study).计算机断层扫描测量的内脏脂肪面积绝对值与日本大规模一般人群肥胖相关心血管危险因素的关系(VACATION-J 研究)。
Ann Med. 2012 Feb;44(1):82-92. doi: 10.3109/07853890.2010.526138. Epub 2010 Oct 22.
10
Impact of visceral fat on gene expression profile in peripheral blood cells in obese Japanese subjects.内脏脂肪对肥胖日本受试者外周血细胞基因表达谱的影响。
Cardiovasc Diabetol. 2016 Nov 29;15(1):159. doi: 10.1186/s12933-016-0479-1.

引用本文的文献

1
Predicting circadian syndrome by obesity indices in middle-aged and older Chinese: evidence from the China Health and Retirement Longitudinal Study.利用肥胖指数预测中国中老年人的昼夜节律综合征:来自中国健康与养老追踪调查的证据
Int J Cardiol Cardiovasc Risk Prev. 2025 Jul 1;26:200465. doi: 10.1016/j.ijcrp.2025.200465. eCollection 2025 Sep.
2
The Critical Role of Body Composition Assessment in Advancing Research and Clinical Health Risk Assessment across the Lifespan.身体成分评估在推进全生命周期研究及临床健康风险评估中的关键作用。
J Obes Metab Syndr. 2025 Apr 30;34(2):120-137. doi: 10.7570/jomes25010. Epub 2025 Apr 8.
3
Uremic sarcopenia: the role of intramuscular adipose tissue as a potential early identifier.
尿毒症性肌肉减少症:肌肉内脂肪组织作为潜在早期识别指标的作用
Front Med (Lausanne). 2024 Nov 1;11:1372668. doi: 10.3389/fmed.2024.1372668. eCollection 2024.
4
Prevalence of metabolic syndrome and its components according to altitude levels: a systematic review and meta-analysis.根据海拔高度分层的代谢综合征及其组分的流行率:系统评价和荟萃分析。
Sci Rep. 2024 Nov 11;14(1):27581. doi: 10.1038/s41598-024-77928-z.
5
The effect of bariatric-metabolic surgery on selected components of metabolic syndrome and visceral adipose tissue - the pilot study.减重代谢手术对代谢综合征和内脏脂肪组织部分成分的影响:一项初步研究。
Physiol Res. 2023 Dec 29;72(S5):S523-S534. doi: 10.33549/physiolres.935227.
6
Association of time-restricted feeding, arterial age, and arterial stiffness in adults with metabolic syndrome.限时进食、动脉年龄与代谢综合征成人动脉僵硬度之间的关联。
Health Sci Rep. 2023 Jul 3;6(7):e1385. doi: 10.1002/hsr2.1385. eCollection 2023 Jul.
7
Visceral Obesity and Lipid Profiles in Chinese Adults with Normal and High Body Mass Index.中国正常和高体重指数成年人的内脏肥胖与血脂谱
Diagnostics (Basel). 2022 Oct 17;12(10):2522. doi: 10.3390/diagnostics12102522.
8
Prognostic Value of Metabolic Syndrome in Patients With Non-ST Elevated Myocardial Infarction Undergoing Percutaneous Coronary Intervention.代谢综合征在接受经皮冠状动脉介入治疗的非ST段抬高型心肌梗死患者中的预后价值
Front Cardiovasc Med. 2022 Jun 23;9:912999. doi: 10.3389/fcvm.2022.912999. eCollection 2022.
9
Optimal Obesity- and Lipid-Related Indices for Predicting Metabolic Syndrome in Chronic Kidney Disease Patients with and without Type 2 Diabetes Mellitus in China.中国合并与不合并 2 型糖尿病的慢性肾脏病患者中预测代谢综合征的最佳肥胖和血脂相关指标。
Nutrients. 2022 Mar 23;14(7):1334. doi: 10.3390/nu14071334.
10
Prevalence of Overweight and Obesity among Students of University in Pristina/Kosovska Mitrovica, according to Different Anthropometric Indices.根据不同人体测量指标,普里什蒂纳/科索沃米特罗维察大学学生中超重和肥胖的患病率
Iran J Public Health. 2021 Sep;50(9):1919-1921. doi: 10.18502/ijph.v50i9.7078.